Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.
MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...
MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.025 | 1.28205128205 | 1.95 | 2.06 | 1.6 | 34605 | 1.93626125 | CS |
4 | -0.165 | -7.71028037383 | 2.14 | 2.63 | 1.6 | 51608 | 2.23095262 | CS |
12 | -0.5551 | -21.9398442749 | 2.5301 | 3.54 | 1.6 | 45910 | 2.24038054 | CS |
26 | -1.895 | -48.9664082687 | 3.87 | 3.9899 | 1.6 | 44447 | 2.70191159 | CS |
52 | -13.1 | -86.8988391376 | 15.075 | 26.4675 | 1.6 | 1973595 | 17.11888208 | CS |
156 | -1393.025 | -99.8584229391 | 1395 | 2013.75 | 1.6 | 1797302 | 341.8651411 | CS |
260 | -6421.775 | -99.9692547188 | 6423.75 | 14130 | 1.6 | 1146781 | 710.49741879 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約